An advisory panel to the
Food and Drug Administration
heartburn drug Prilosec be approved for sale over the counter.
The recommendation will go to the FDA, which usually follows the advice of its panels, but the agency has no obligation to do so.
Procter & Gamble
owns the rights to distribute the nonprescription formulation of Prilosec and asked the FDA to approve the drug for over-the-counter sales.
Shares of AstraZeneca ended Friday up 1.6% to $40.35, while P&G was unchanged at $93.85.